Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
China
26 Articles Available
1
2
Can't find what you're looking for? Try our
advanced search
.
Drug Supply
BeiGene Announces Supply Update for ABRAXANE in China
PR-M03-20-NI-037
Drug Development
WuXi Biologics Congratulates Tychan on the World’s First Yellow Fever Antibody Tested Safe and Efficacious in Human Volunteers
PR-M11-19-NI-018
China
GE Healthcare Life Sciences and Akeso Pharmaceuticals to Speed Up Novel Therapy Manufacturing in China
PR-M11-19-NI-015
Strategic Collaboration
Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China
PR-M10-19-NI-048
R&D
Covance Unveils New R&D Center in Shanghai
PR-M09-19-NI-038
M&A
Zhejiang Jiuzhou to Acquire Suzhou Unit of Novartis AG for CNY790 Million
PAO-M09-19-NI-009
Licensing Agreement
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
PR-M08-19-NI-076
Collaboration
iBio and CC-Pharming Expand Business Collaboration in China
PR-M08-19-NI-087
Research
Hybrid Human/Monkey Embryos Created by Salk Researchers in China
PAO-M08-19-NI-027
Drug Pricing
China Welcomes Indian Competition in Push to Lower Drug Costs
PAO-M08-19-NI-010
Generics
China Eases Generic Drug Market Shake-Up
PAO-M08-19-NI-001
Biosimilars
Celltrion and Nan Fung Group to establish Vcell Healthcare Limited to Develop and Commercialize Biosimilars in China
PR-M07-19-NI-058
Gene Editing
China to Introduce Regulations on Gene Editing
PAO-M05-19-NI-031
Consumer Healthcare
GSK and Pfizer’s Combined Consumer Healthcare Business Will Focus on the U.S. and China
PAO-M04-19-NI-016
Oncology Drugs
China Cancer Drugs Market 2018-2024: Rising Demand of Targeted Drug Therapy and the Patent Expiration of Key Cancer Drugs
PR-M01-19-NI-044
New Facility
Pall Opens Center of Excellence in Shanghai
PR-M12-18-NI-080
Immunotherapy
I-Mab and Genexine Announce China IND Approval for Innovative Immunotherapy
PR-M11-18-NI-014
Investment
Foreign Investment: Chinese Capital Backs U.S. Biotech
PAP-Q4-18-NI-008
Clinical Study
Yisheng Biopharma Announces Clearance from China FDA to Proceed with PIKA Rabies Vaccine Clinical Study
PR-M10-18-NI-028
New Drug Application
AVEO Announces Acceptance of CANbridge Investigational New Drug Application for CAN017 (AV-203) Trial in Esophageal Squamous Cell Cancer (ESCC) in China
PR-M09-18-NI-029
Patent Application
Relmada Therapeutics Allowed Patent Application in China Covering NMDA Receptor Antagonist d-Methadone for Treatment of Psychiatric Symptoms
PR-M08-18-NI-118
Clinical Trial
I-Mab's Announces China Clinical Trial Approval of Long-acting hGLP-1 to Treat Type 2 Diabetes
PR-M08-18-NI-116
Regulatory
China to Accelerate Review of 48 Foreign Drugs
PAO-M08-18-NI-013
China
Big Pharma Companies Taking New Drugs to China First
PAO-M08-18-NI-010
1
2
»